A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function

Free Radical Biology and Medicine

Volumn 47, Issue 11, 2009, Pages 1584-1590

  Rudolph, Volker ^a   Rudolph, Tanja K ^a   Kubala, Lukas ^b   Clauberg, Navina ^c   Maas, Renke ^d   Pekarova, Michaela ^b   Klinke, Anna ^a   Lau, Denise ^a   Szöcs, Katalin ^a   Meinertz, Thomas ^a   Böger, Rainer H ^c   Baldus, Stephan ^a  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Free radicals; Genetics; Heart failure; Myeloperoxidase; Survival

Indexed keywords

ALANINE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLYCINE; MYELOPEROXIDASE;

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SURVIVAL TIME;

AGED; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 70350620976     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.09.001     Document Type: Article

References (34)

1. Zhang R., Brennan M.L., Fu X., Aviles R.J., Pearce G.L., Penn M.S., Topol E.J., Sprecher D.L., and Hazen S.L. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
2. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukocyte Biol. 77 (2005) 598-625
3. Hansson M., Olsson I., and Nauseef W.M. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch. Biochem. Biophys. 445 (2006) 214-224
4. Tang W.H., Brennan M.L., Philip K., Tong W., Mann S., Van L.F., and Hazen S.L. Plasma myeloperoxidase levels in patients with chronic heart failure. Am. J. Cardiol. 98 (2006) 796-799
5. Rudolph V., Rudolph T.K., Hennings J.C., Blankenberg S., Schnabel R., Steven D., Haddad M., Knittel K., Wende S., Wenzel J., Munzel T., Heitzer T., Meinertz T., Hubner C., and Baldus S. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic. Biol. Med. 43 (2007) 1189-1196
6. Tang W.H., Tong W., Troughton R.W., Martin M.G., Shrestha K., Borowski A., Jasper S., Hazen S.L., and Klein A.L. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J. Am. Coll. Cardiol. 49 (2007) 2364-2370
7. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.J., Nauseef W.M., White C.R., and Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
8. Baldus S., Eiserich J.P., Mani A., Castro L., Figueroa M., Chumley P., Ma W., Tousson A., White C.R., Bullard D.C., Brennan M.L., Lusis A.J., Moore K.P., and Freeman B.A. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest. 108 (2001) 1759-1770
9. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 103 (1999) 1547-1560
10. Vasilyev N., Williams T., Brennan M.L., Unzek S., Zhou X., Heinecke J.W., Spitz D.R., Topol E.J., Hazen S.L., and Penn M.S. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 112 (2005) 2812-2820
11. Askari A.T., Brennan M.L., Zhou X., Drinko J., Morehead A., Thomas J.D., Topol E.J., Hazen S.L., and Penn M.S. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J. Exp. Med. 197 (2003) 615-624
12. Ng L.L., Pathik B., Loke I.W., Squire I.B., and Davies J.E. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. Am. Heart J. 152 (2006) 94-101
13. Braunwald E. Biomarkers in heart failure. N. Engl. J. Med. 358 (2008) 2148-2159
14. Reynolds W.F., Chang E., Douer D., Ball E.D., and Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood 90 (1997) 2730-2737
15. Baldus S., Heitzer T., Eiserich J.P., Lau D., Mollnau H., Ortak M., Petri S., Goldmann B., Duchstein H.J., Berger J., Helmchen U., Freeman B.A., Meinertz T., and Munzel T. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic. Biol. Med. 37 (2004) 902-911
16. Nikpoor B., Turecki G., Fournier C., Theroux P., and Rouleau G.A. A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am. Heart J. 142 (2001) 336-339
17. Freedman L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat. Med. 1 (1982) 121-129
18. Lunetta K.L. Genetic association studies. Circulation 118 (2008) 96-101
19. Reynolds W.F., Patel K., Pianko S., Blatt L.M., Nicholas J.J., and McHutchison J.G. A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis C virus infection. Genes Immun. 3 (2002) 345-349
20. Nagra R.M., Becher B., Tourtellotte W.W., Antel J.P., Gold D., Paladino T., Smith R.A., Nelson J.R., and Reynolds W.F. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78 (1997) 97-107
21. Reynolds W.F., Sermet-Gaudelus I., Gausson V., Feuillet M.N., Bonnefont J.P., Lenoir G., scamps-Latscha B., and Witko-Sarsat V. Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. Mediators Inflammation 2006 (2006) 36735
22. Makela R., Karhunen P.J., Kunnas T.A., Ilveskoski E., Kajander O.A., Mikkelsson J., Perola M., Penttila A., and Lehtimaki T. Myeloperoxidase gene variation as a determinant of atherosclerosis progression in the abdominal and thoracic aorta: an autopsy study. Lab. Invest. 83 (2003) 919-925
23. Makela R., Laaksonen R., Janatuinen T., Vesalainen R., Nuutila P., Jaakkola O., Knuuti J., and Lehtimaki T. Myeloperoxidase gene variation and coronary flow reserve in young healthy men. J. Biomed. Sci. 11 (2004) 59-64
24. Asselbergs F.W., Tervaert J.W., and Tio R.A. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 350 (2004) 516-518
25. Torre-Amione G. Immune activation in chronic heart failure. Am. J. Cardiol. 95 (2005) 3C-8C
26. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., and Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271 (1996) 14412-14420
27. Rutgers A., Heeringa P., Giesen J.E., Theunissen R.T., Jacobs H., and Tervaert J.W. Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms. Br. J. Haematol. 123 (2003) 536-538
28. Chevrier I., Tregouet D.A., Massonnet-Castel S., Beaune P., and Loriot M.A. Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis?. Atherosclerosis 188 (2006) 150-154
29. Winterbourn C.C., Hampton M.B., Livesey J.H., and Kettle A.J. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J. Biol. Chem. 281 (2006) 39860-39869
30. Hoy A., Tregouet D., Leininger-Muller B., Poirier O., Maurice M., Sass C., Siest G., Tiret L., and Visvikis S. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur. J. Hum. Genet. 9 (2001) 780-786
31. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., Simoons M.L., and Hamm C.W. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
32. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E.J., Nissen S.E., and Hazen S.L. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 349 (2003) 1595-1604
33. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N. Engl. J. Med. 347 (2002) 5-12
34. Mocatta T.J., Pilbrow A.P., Cameron V.A., Senthilmohan R., Frampton C.M., Richards A.M., and Winterbourn C.C. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J. Am. Coll. Cardiol. 49 (2007) 1993-2000